Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
De-Escalate Trial: Atazanavir Substitution in HIV
NCT00160329Phase 3Completed
- Sponsor
- Stanford University
- Start
- Jan 2004
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atazanavir in human immunodeficiency virus infection (HIV), sponsored by Stanford University. Started Jan 2004; status: completed.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00160329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00160329.